TSHA vs. ATRO
TSHA (Taysha Gene Therapies, Inc.) and ATRO (Astronics Corporation) are both stocks. TSHA operates in Biotechnology (Healthcare), while ATRO operates in Aerospace & Defense (Industrials). Over the past 5 years, TSHA returned -19.46%/yr vs 38.51%/yr for ATRO. Their 0.18 correlation means their historical movements had little consistent relationship.
Performance
TSHA vs. ATRO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TSHA achieves a 6.55% return, which is significantly lower than ATRO's 60.53% return.
TSHA
- 1D
- -0.26%
- 1M
- -10.26%
- 6M
- 29.93%
- YTD
- 6.55%
- 1Y
- 122.81%
- 3Y*
- 105.27%
- 5Y*
- -19.46%
- 10Y*
- —
- ALL TIME*
- -20.40%
ATRO
- 1D
- 1.58%
- 1M
- -1.89%
- 6M
- 14.95%
- YTD
- 60.53%
- 1Y
- 154.15%
- 3Y*
- 59.32%
- 5Y*
- 38.51%
- 10Y*
- 10.43%
- ALL TIME*
- 16.08%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $31.84M | $40.05M | $53.09M | |
| $12.94M | $17.27M | $18.69M |
TSHA vs. ATRO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
TSHA Taysha Gene Therapies, Inc. | 6.55% | 217.92% | -2.26% | -21.68% | -80.60% | -56.10% | 19.28% |
ATRO Astronics Corporation | 60.53% | 239.85% | -8.38% | 69.13% | -14.17% | -9.30% | 67.47% |
Correlation
The correlation between TSHA and ATRO is 0.30, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.30 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.18 |
Correlation (All Time) Calculated using the full available price history since Sep 24, 2020 | 0.18 |
The correlation between TSHA and ATRO shifts across timeframes, from 0.18 (5 years) to 0.30 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
TSHA:
$1.87B
ATRO:
$2.67B
TSHA:
-$0.37
ATRO:
$1.21
TSHA:
271.82
ATRO:
2.93
TSHA:
10.14
ATRO:
16.43
TSHA:
$7.47M
ATRO:
$886.81M
TSHA:
$6.89M
ATRO:
$272.44M
TSHA:
-$130.51M
ATRO:
$74.47M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TSHA vs. ATRO — Risk / Return Rank
TSHA
ATRO
TSHA vs. ATRO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Taysha Gene Therapies, Inc. (TSHA) and Astronics Corporation (ATRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TSHA | ATRO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.27 | ||
| Sortino ratioReturn per unit of downside risk | -0.46 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.39 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 3.70 | 5.62 | -1.92 |
| Martin ratioReturn relative to average drawdown | 7.37 | 16.07 | -8.69 |
Loading charts...
Drawdowns
TSHA vs. ATRO - Drawdown Comparison
The maximum TSHA drawdown since its inception was -98.14%, which is greater than ATRO's maximum drawdown of -90.12%. Use the drawdown chart below to compare losses from any high point for TSHA and ATRO.
Loading charts...
Drawdown Indicators
| TSHA | ATRO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.14% | -90.12% | -8.02% |
Max Drawdown (1Y)Largest decline over 1 year | -31.13% | -25.26% | -5.87% |
Max Drawdown (3Y)Largest decline over 3 years | -72.90% | -33.30% | -39.60% |
Max Drawdown (5Y)Largest decline over 5 years | -97.26% | -54.13% | -43.13% |
Max Drawdown (10Y)Largest decline over 10 years | — | -85.52% | — |
Current DrawdownCurrent decline from peak | -81.54% | -20.26% | -61.28% |
Average DrawdownAverage peak-to-trough decline | -76.92% | -38.00% | -38.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.61% | 8.85% | +6.76% |
Volatility
TSHA vs. ATRO - Volatility Comparison
Taysha Gene Therapies, Inc. (TSHA) has a higher volatility of 23.33% compared to Astronics Corporation (ATRO) at 14.47%. This indicates that TSHA's price experiences larger fluctuations and is considered to be riskier than ATRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TSHA | ATRO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.33% | 14.47% | +8.86% |
Volatility (6M)Calculated over the trailing 6-month period | 51.71% | 39.88% | +11.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 90.03% | 55.61% | +34.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 136.69% | 55.10% | +81.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 129.49% | 57.03% | +72.46% |
Dividends
TSHA vs. ATRO - Dividend Comparison
Neither TSHA nor ATRO has paid dividends to shareholders.
Financials
TSHA vs. ATRO - Financials Comparison
This section allows you to compare key financial metrics between Taysha Gene Therapies, Inc. and Astronics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TSHA and ATRO have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TSHA has higher volatility (23.33%) compared to ATRO (14.47%). In terms of maximum drawdown, TSHA dropped -98.14% vs ATRO's -90.12%.
ATRO currently has the higher Sharpe Ratio (2.55 vs 1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TSHA and ATRO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer